CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on ...
A continuous glucose monitor, or CGM, is a wearable device that tracks glucose around the clock instead of capturing a single ...
For decades, watching your blood sugar move in real time required a prescription, a finger prick or both. That barrier is ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results